Clinton Health Access INitiative
The Clinton Health Access Initiative (CHAI) is a global nonprofit health organisation that strengthens integrated health systems in the developing world and expands access to care and treatment for HIV/AIDS, malaria and tuberculosis.
Based on the premise that business-oriented strategy can facilitate solutions to global health challenges, CHAI acts as a catalyst to mobilise new resources and optimize the impact of these resources to save lives, via improved organization of commodity markets and more effective national and sub-national level management. CHAI will apply the techniques it has used successfully to improve access to HIV/AIDS and malaria treatment in developing countries to achieve the same for essential vaccines. Immunisation is widely acknowledged as the most cost-effective and focused disease intervention and yet each year an estimated three million children under the age of five lose their lives to preventable illnesses. A majority of these deaths occur in low-income countries, where poverty and lack of affordability prevent access to life-saving vaccines. There is an unprecedented wave of new vaccines expected to become available within the next decade that could transform the global burden of disease. However, the cost of deploying these products while maintaining access to current vaccines is expected to exceed $4 billion annually by 2015. Given the current difficult financial climate, governments and donors may be unable to meet the escalating cost burden generated by these new products. As a result, the pricing and market conditions of new and existing vaccines will be a critical determinant of coverage levels and, therefore, health impact in the coming years. By working with key stakeholders, CHAI Vaccine Markets programme aims to support the achievement of affordable yet sustainable vaccine prices and supply, thereby increasing value for money and enabling accelerated introduction of new vaccines in developing countries.
CHAI seeks to appoint a Senior Vaccines Analyst. The job location is flexible.
As part of the global Vaccine Markets team, the Senior Analyst is expected to support the achievement of affordable yet sustainable global vaccine prices and supply, including but not limited to the following responsibilities:
- Develop a detailed understanding and documentation of vaccine production dynamics including production capacity of key manufacturers, production technologies and their costs, cost reduction strategies, product development and manufacturing timelines, and manufacturers' vaccine development and marketing strategies;
- Develop a detailed understanding of the global vaccine market for priority vaccines including an understanding of the vaccine demand and supply forecasts and potential prices and supply timelines
- Develop and maintain a current understanding of international regulatory standards including World Health Organization (WHO) prequalification for vaccines and Good Manufacturing Practices (GMP) and quality assurance and quality control best practices;
- Support key partners and vaccine manufacturers to develop, implement and monitor plans to make vaccines available at affordable prices and to develop products that meet the needs of low income countries;
- Screen vaccine suppliers in emerging markets, examining their product portfolio and pipeline, regulatory status and potential, and production capacity, among other components;
- Cultivate relationships with suppliers that have the potential to become significant, quality-assured producers of relevant new vaccines for developing markets;
- Build and maintain these relationships by providing valuable market insights and contacts, offering targeted support and guidance to navigate regulatory and procurement processes;
- Link manufacturers to stakeholders in high volume countries and provide insight on country-specific product preferences that may affect supply decisions;
- Prepare presentations, reports, and other analyses to inform global vaccines policy and increase the evidence base for high-impact interventions to accelerate new vaccine introduction and improve affordability and accessibility;
- Any other duties as required by the Director - Vaccine Markets.
- Minimum of three years of experience in the pharmaceutical, healthcare, and/or biotechnology. Experience with vaccines will be strongly preferred. Potential candidate profiles include vaccine business development, manufacturing or product management and commercialisation, or some combination thereof. Candidates with sufficient experience can be considered for a Vaccines Manager position instead of an analyst position;
- Management consultants with experience in pharmaceuticals or vaccines are encouraged to apply;
- Minimum: Bachelor’s degree, preferably in science, economics or a public health-related field;
- MBA or advanced degree in science or public health will be preferred;
- Outstanding analytical and problem solving skills, including experience with modelling and conducting quantitative and statistical analyses;
- Excellent oral and written communication skills;
- Ability to work independently and effectively in high-pressure, fast-paced environment and handle multiple tasks simultaneously;
- High levels of proficiency in Microsoft Word, Excel, PowerPoint, and internet applications;
- Experience working in emerging markets and fluency in local languages are an added advantage.
Apply online, click here.
For more about the Clinton Health Access Initiative, refer to www.clintonhealthaccess.org.
For other vacancies in the NGO sector, refer to www.ngopulse.org/vacancies.
Follow and support the 2012 SANGONeT "No Pain No Gain" fundraising and awareness-raising campaign. Refer to www.ngopulse.org/npng for more information.